C.F.R. homeSearch C.F.R.
C.F.R.Title 49Part 40—Procedures for Transportation Workplace Drug and Alcohol Testing ProgramsSubpart F—Drug Testing Laboratories

49 C.F.R. § 40.91 (2026)

What are the cutoff concentrations for oral fluid drug tests?

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 2003 2citing cases
At a glance

Courts have cited this section in 2 opinions since 2003.

As a laboratory, you must use the cutoff concentrations displayed in the following table for initial and confirmatory drug tests for oral fluid specimens. All cutoff concentrations are expressed in nanograms per milliliter (ng/mL). The table follows:

Table 1 to § 40.91—Oral Fluid Testing Cutoff Concentrations

Initial test analyteInitial test
cutoff 1
Confirmatory test analyteConfirmatory test cutoff concentration
Marijuana (THC) 24 ng/mL 3THC2 ng/mL.
Cocaine/Benzoylecgonine15 ng/mL
Cocaine
Benzoylecgonine
8 ng/mL.
8 ng/mL.
Codeine/Morphine30 ng/mL
Codeine
Morphine
15 ng/mL.
15 ng/mL.
Hydrocodone/Hydromorphone30 ng/mL
Hydrocodone
Hydromorphone
15 ng/mL.
15 ng/mL.
Oxycodone/Oxymorphone30 ng/mL
Oxycodone
Oxymorphone
15 ng/mL.
15 ng/mL.
6-Acetylmorphine4 ng/mL 36-Acetylmorphine2 ng/mL.
Phencyclidine10 ng/mLPhencyclidine10 ng/mL.
Amphetamine/Methamphetamine50 ng/mL
Amphetamine
Methamphetamine
25 ng/mL.
25 ng/mL.
MDMA 4/MDA 550 ng/mL
MDMA
MDA
25 ng/mL.
25 ng/mL.
1 For grouped analytes (i.e., two or more analytes that are in the same drug class and have the same initial test cutoff):
Immunoassay: The test must be calibrated with one analyte from the group identified as the target analyte. The cross reactivity of the immunoassay to the other analyte(s) within the group must be 80 percent or greater; if not, separate immunoassays must be used for the analytes within the group.
Alternate technology: Either one analyte or all analytes from the group must be used for calibration, depending on the technology. At least one analyte within the group must have a concentration equal to or greater than the initial test cutoff or, alternatively, the sum of the analytes present (i.e., with concentrations equal to or greater than the laboratory's validated limit of quantification) must be equal to or greater than the initial test cutoff.
2 An immunoassay must be calibrated with the target analyte.
3Alternate technology (THC and 6-AM): The confirmatory test cutoff must be used for an alternate technology initial test that is specific for the target analyte (i.e., 2 ng/mL for THC, 2 ng/mL for 6-AM).
4 Methylenedioxymethamphetamine (MDMA).
5 Methylenedioxyamphetamine (MDA).
[88 FR 27643, May 2, 2023]
The 2 cases that cite 49 C.F.R. § 40.91 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENBarry M. Cornish v. Marion C. Blakey, 336 F.3d 749 (8th Cir. 2003).
cites § 40.91 1×cited by 6 cases
Where it cites § 40.91
“See 49 C.F.R. § 40.91 , 40.95, 40.97. This rule supersedes the 1998 DOT memorandum.”
2
GREENBarry M. Cornish v. Jane Garvey, No. 02-2912 (8th Cir. July 18, 2003).
cites § 40.91 1×cited by 0 cases
Where it cites § 40.91
“See 49 C.F.R. § 40.91 , 40.95, 40.97. This rule supersedes the 1998 DOT memorandum.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com